STRATA CRITICAL MEDICAL, INC. Current State and Local Tax Expense (Benefit)
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Current State and Local Tax Expense (Benefit) of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2025-03-13
- STRATA CRITICAL MEDICAL, INC. current state and local tax expense (benefit) for the quarter ending 2021-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. current state and local tax expense (benefit) for the quarter ending 2020-12-31 was $0.00.
- STRATA CRITICAL MEDICAL, INC. current state and local tax expense (benefit) for fiscal 2024 was $0.00.
- STRATA CRITICAL MEDICAL, INC. current state and local tax expense (benefit) for fiscal 2023 was $0.00.
- STRATA CRITICAL MEDICAL, INC. current state and local tax expense (benefit) for fiscal 2022 was $0.00.
- STRATA CRITICAL MEDICAL, INC. current state and local tax expense (benefit) for fiscal 2021 was $0.00.
| Period end | Current State and Local Tax Expense (Benefit) 3 month | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-13 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-13 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-12 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |
| 2021-09-30 | $0.00 10-K · filed 2023-03-16 | |
| 2020-12-31 | $0.00 8-K · filed 2023-01-10 | $39.82K 10-K/A · filed 2021-05-07 |
| 2020-09-30 | $0.00 10-K · filed 2021-12-20 | |
| 2019-12-31 | $0.00 10-K/A · filed 2021-05-07 | |
| 2019-09-30 | $0.00 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |